Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Padagis
Minneapolis, Minnesota, United Statespadagis.com ↗
- Ownership
- Private
- Employees
- ~1300
- Development stage
- Other
01
Overview
Padagis specializes in developing and manufacturing high-quality generic prescription and OTC pharmaceutical products with a focus on extended topical formulations. The company has successfully launched first-to-file and first-to-market generics—including the first OTC naloxone nasal spray—helping to make medications more affordable for patients.
- Therapeutic areas
- GastroenterologyCardiovascularInfectious DiseasesWomen's Health
- Modalities
- Small moleculeTopical formulation (creams, ointments, gels, foams, sprays, patches)Nasal spraySuppositoryInhalable product
- Industry
- Biotech
02
Partnerships
Licensing agreementsjoint ventures for marketing/distribution/product acquisition—specific partners not named publicly.
Beyond the preview
Go deeper on Padagis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Padagis.